{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:51:17Z","timestamp":1791528677775,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.bcp.2021.114470","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T15:36:46Z","timestamp":1613749006000},"page":"114470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Antimicrobial peptides with symmetric structures against multidrug-resistant bacteria while alleviating antimicrobial resistance"],"prefix":"10.1016","volume":"186","author":[{"given":"Chao","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuewen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanhu","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingman","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2021.114470_b0005","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41586-019-1665-6","article-title":"Chimeric peptidomimetic antibiotics against Gram-negative bacteria","volume":"576","author":"Luther","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2021.114470_b0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert review of anti-infective therapy"},{"key":"10.1016\/j.bcp.2021.114470_b0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.drup.2016.04.002","article-title":"Mechanisms and consequences of bacterial resistance to antimicrobial peptides","volume":"26","author":"Andersson","year":"2016","journal-title":"Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"key":"10.1016\/j.bcp.2021.114470_b0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fphar.2013.00168","article-title":"Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them","volume":"4","author":"Amaral","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114470_b0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan4044","article-title":"The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms","volume":"10","author":"de Breij","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2021.114470_b0030","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1176667","article-title":"Antibiotics for emerging pathogens","volume":"325","author":"Fischbach","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bcp.2021.114470_b0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.micro.54.1.49","article-title":"Biofilm formation as microbial development","volume":"54","author":"O'Toole","year":"2000","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.bcp.2021.114470_b0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/joim.12242","article-title":"Microbial biofilm formation: a need to act","volume":"276","author":"Romling","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bcp.2021.114470_b0045","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03258-19","article-title":"Romo1-derived antimicrobial peptide is a new antimicrobial agent against multidrug-resistant bacteria in a murine model of sepsis","volume":"11","author":"Lee","year":"2020","journal-title":"mBio."},{"key":"10.1016\/j.bcp.2021.114470_b0050","doi-asserted-by":"crossref","unstructured":"E. Meade, M.A. Slattery, M. Garvey, Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile? Antibiotics. 2020;9.","DOI":"10.3390\/antibiotics9010032"},{"key":"10.1016\/j.bcp.2021.114470_b0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11908-017-0596-3","article-title":"Polymyxin Resistance in Gram-negative Pathogens","volume":"19","author":"Srinivas","year":"2017","journal-title":"Current infectious disease reports"},{"key":"10.1016\/j.bcp.2021.114470_b0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.omto.2019.12.001","article-title":"In vitro and MD simulation study to explore physicochemical parameters for antibacterial peptide to become potent anticancer peptide","volume":"16","author":"Ma","year":"2020","journal-title":"Molecular Therapy Oncolytics"},{"key":"10.1016\/j.bcp.2021.114470_b0065","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1016\/j.jmb.2018.12.015","article-title":"Peptide design principles for antimicrobial applications","volume":"431","author":"Torres","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcp.2021.114470_b0070","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1021\/acsinfecdis.7b00076","article-title":"Hydrophilic phage-mimicking membrane active antimicrobials reveal nanostructure-dependent activity and selectivity","volume":"3","author":"Jiang","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bcp.2021.114470_b0075","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2174\/0929867321666140217110155","article-title":"Antimicrobial peptides: promising compounds against pathogenic microorganisms","volume":"21","author":"Cruz","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bcp.2021.114470_b0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bcp.2016.09.018","article-title":"Antimicrobial peptides (AMPs): Ancient compounds that represent novel weapons in the fight against bacteria","volume":"133","author":"Ageitos","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114470_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/biom9060242","article-title":"LFB: a novel antimicrobial brevinin-like peptide from the skin secretion of the fujian large headed frog, Limnonectes fujianensi","volume":"9","author":"Li","year":"2019","journal-title":"Biomolecules."},{"key":"10.1016\/j.bcp.2021.114470_b0090","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1002\/anie.201914304","article-title":"A glycosylated cationic block poly(beta-peptide) reverses intrinsic antibiotic resistance in all ESKAPE gram-negative bacteria","volume":"59","author":"Si","year":"2020","journal-title":"Angew. Chem."},{"key":"10.1016\/j.bcp.2021.114470_b0095","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1021\/acsinfecdis.9b00123","article-title":"AcrAB-TolC inhibition by peptide-conjugated phosphorodiamidate morpholino oligomers restores antibiotic activity in vitro and in vivo","volume":"5","author":"Sturge","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bcp.2021.114470_b0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fnins.2017.00073","article-title":"Membrane active antimicrobial peptides: translating mechanistic insights to design","volume":"11","author":"Li","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bcp.2021.114470_b0105","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/med.21542","article-title":"Antimicrobial peptides: promising alternatives in the post feeding antibiotic era","volume":"39","author":"Wang","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bcp.2021.114470_b0110","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.bbagen.2017.03.024","article-title":"Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine","volume":"1861","author":"Bacalum","year":"2017","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"key":"10.1016\/j.bcp.2021.114470_b0115","doi-asserted-by":"crossref","first-page":"11906","DOI":"10.1021\/jp405418y","article-title":"The different interactions of lysine and arginine side chains with lipid membranes","volume":"117","author":"Li","year":"2013","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bcp.2021.114470_b0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.actbio.2018.01.009","article-title":"Central beta-turn increases the cell selectivity of imperfectly amphipathic alpha-helical peptides","volume":"69","author":"Shao","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2021.114470_b0125","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.bbamem.2012.12.002","article-title":"Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria","volume":"1828","author":"Torcato","year":"2013","journal-title":"BBA"},{"key":"10.1016\/j.bcp.2021.114470_b0130","doi-asserted-by":"crossref","first-page":"12145","DOI":"10.1021\/jp4068729","article-title":"Why do arginine and lysine organize lipids differently? Insights from coarse-grained and atomistic simulations","volume":"117","author":"Wu","year":"2013","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bcp.2021.114470_b0135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1677\/joe.0.1790447","article-title":"A comparative study of amino acid consumption by rat islet cells and the clonal beta-cell line BRIN-BD11 - the functional significance of L-alanine","volume":"179","author":"Dixon","year":"2003","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bcp.2021.114470_b0140","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.actbio.2015.11.002","article-title":"Short, multiple-stranded beta-hairpin peptides have antimicrobial potency with high selectivity and salt resistance","volume":"30","author":"Chou","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2021.114470_b0145","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1039\/C9BM00044E","article-title":"Short, symmetric-helical peptides have narrow-spectrum activity with low resistance potential and high selectivity","volume":"7","author":"Chou","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bcp.2021.114470_b0150","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1038\/s41598-019-40577-8","article-title":"Development of a novel short 12-meric papiliocin-derived peptide that is effective against Gram-negative sepsis","volume":"9","author":"Kim","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2021.114470_b0155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3389\/fmicb.2020.00537","article-title":"Peptides with triplet-tryptophan-pivot promoted pathogenic bacteria membrane defects","volume":"11","author":"Chou","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bcp.2021.114470_b0160","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1021\/acs.biochem.7b00456","article-title":"The pi configuration of the WWW motif of a short trp-rich peptide is critical for targeting bacterial membranes, disrupting preformed biofilms, and killing methicillin-resistant Staphylococcus aureus","volume":"56","author":"Zarena","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2021.114470_b0165","doi-asserted-by":"crossref","first-page":"43820","DOI":"10.1021\/acsami.9b12706","article-title":"Therapeutic potential of Trp-rich engineered amphiphiles by single hydrophobic amino acid end-tagging","volume":"11","author":"Song","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bcp.2021.114470_b0170","doi-asserted-by":"crossref","first-page":"17584","DOI":"10.1074\/jbc.M109.011650","article-title":"Boosting antimicrobial peptides by hydrophobic oligopeptide end tags","volume":"284","author":"Schmidtchen","year":"2009","journal-title":"J. Biolog. Chem."},{"key":"10.1016\/j.bcp.2021.114470_b0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.febslet.2006.12.003","article-title":"Interaction mode of a symmetric Trp-rich undeca peptide PST11-RK with lipid bilayers","volume":"581","author":"Yang","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2021.114470_b0180","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijantimicag.2005.11.014","article-title":"Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities","volume":"27","author":"Yang","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bcp.2021.114470_b0185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00726-015-2094-y","article-title":"Rational design of mirror-like peptides with alanine regulation","volume":"48","author":"Li","year":"2016","journal-title":"Amino Acids"},{"key":"10.1016\/j.bcp.2021.114470_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061417","article-title":"Symmetrical modification of minimized dermaseptins to extend the spectrum of antimicrobials with endotoxin neutralization potency","volume":"20","author":"Shao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2021.114470_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111636","article-title":"Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity","volume":"182","author":"Zhong","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2021.114470_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105123","article-title":"Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria","volume":"141","author":"Zhong","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.bcp.2021.114470_b0205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.diagmicrobio.2013.01.001","article-title":"Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011)","volume":"75","author":"Sader","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bcp.2021.114470_b0210","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.1021\/acs.jmedchem.5b00628","article-title":"N-lipidated peptide dimers: effective antibacterial agents against gram-negative pathogens through lipopolysaccharide permeabilization","volume":"58","author":"Koh","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2021.114470_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmm.2020.151433","article-title":"Synthesis and anti-pseudomonal activity of new ss-Ala modified analogues of the antimicrobial peptide anoplin","volume":"310","author":"Zhong","year":"2020","journal-title":"Int. J. Med. Microbiol.: IJMM."},{"key":"10.1016\/j.bcp.2021.114470_b0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biomaterials.2012.09.032","article-title":"Design of hybrid beta-hairpin peptides with enhanced cell specificity and potent anti-inflammatory activity","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2021.114470_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103871","article-title":"Study on the effects of different dimerization positions on biological activity of partial d-Amino acid substitution analogues of Anoplin","volume":"139","author":"Zhong","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bcp.2021.114470_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106098","article-title":"Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus","volume":"56","author":"Sun","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bcp.2021.114470_b0235","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2147\/IDR.S201124","article-title":"A novel mechanism of action of ketoconazole: inhibition of the NorA efflux pump system and biofilm formation in multidrug-resistant Staphylococcus aureus","volume":"12","author":"Abd El-Baky","year":"2019","journal-title":"Infection Drug Resistance"},{"key":"10.1016\/j.bcp.2021.114470_b0240","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.micpath.2018.08.022","article-title":"Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo","volume":"124","author":"Sundaramoorthy","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bcp.2021.114470_b0245","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2958.2003.03673.x","article-title":"Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa","volume":"50","author":"McPhee","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bcp.2021.114470_b0250","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1046\/j.1365-2958.1998.00757.x","article-title":"PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance","volume":"27","author":"Gunn","year":"1998","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bcp.2021.114470_b0255","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jac\/dkf156","article-title":"Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B","volume":"50","author":"Ulvatne","year":"2002","journal-title":"J. Antimicrobial Chemotherapy"},{"key":"10.1016\/j.bcp.2021.114470_b0260","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1348-0421.2010.00238.x","article-title":"Escherichia coli outer membrane protease OmpT confers resistance to urinary cationic peptides","volume":"54","author":"Hui","year":"2010","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.bcp.2021.114470_b0265","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/mmi.12451","article-title":"A divergent Pseudomonas aeruginosa palmitoyltransferase essential for cystic fibrosis-specific lipid A","volume":"91","author":"Thaipisuttikul","year":"2014","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bcp.2021.114470_b0270","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1016\/j.biomaterials.2014.06.005","article-title":"Antimicrobial potency and selectivity of simplified symmetric-end peptides","volume":"35","author":"Dong","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2021.114470_b0275","doi-asserted-by":"crossref","first-page":"33913","DOI":"10.1074\/jbc.M204928200","article-title":"The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers","volume":"277","author":"Papo","year":"2002","journal-title":"J. Biolog. Chem."},{"key":"10.1016\/j.bcp.2021.114470_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10080320","article-title":"Biological activities of cationicity-enhanced and hydrophobicity-optimized analogues of an antimicrobial peptide, dermaseptin-PS3, from the skin secretion of Phyllomedusa sauvagii","volume":"10","author":"Tan","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.bcp.2021.114470_b0285","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cis.2013.06.009","article-title":"Effect of hydrophobic modifications in antimicrobial peptides","volume":"205","author":"Schmidtchen","year":"2014","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.bcp.2021.114470_b0290","article-title":"Polyprodrug antimicrobials: remarkable membrane damage and concurrent drug release to combat antibiotic resistance of methicillin-resistant Staphylococcus aureus","volume":"14","author":"Cao","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.bcp.2021.114470_b0295","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.actbio.2015.02.023","article-title":"Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different alpha-helical propensity","volume":"18","author":"Zhu","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2021.114470_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183195","article-title":"The effect of lipidation and glycosylation on short cationic antimicrobial peptides","volume":"1862","author":"Grimsey","year":"2020","journal-title":"Biochim. Biophys. Acta, Biomembr."},{"key":"10.1016\/j.bcp.2021.114470_b0305","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ceca.2012.11.012","article-title":"Divalent cations modulate membrane binding and pore formation of a potent antibiotic peptide analog of alamethicin","volume":"53","author":"Aquila","year":"2013","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bcp.2021.114470_b0310","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1042\/BJ20080398","article-title":"An exceptional salt-tolerant antimicrobial peptide derived from a novel gene family of haemocytes of the marine invertebrate Ciona intestinalis","volume":"416","author":"Fedders","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2021.114470_b0315","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bit.25003","article-title":"Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt-resistance, and biocompatibility","volume":"111","author":"Saravanan","year":"2014","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.bcp.2021.114470_b0320","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1016\/j.bbamem.2013.07.020","article-title":"Correlations between membrane immersion depth, orientation, and salt-resistance of tryptophan-rich antimicrobial peptides","volume":"1828","author":"Yu","year":"2013","journal-title":"BBA"},{"key":"10.1016\/j.bcp.2021.114470_b0325","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1021\/jm0703542","article-title":"Albumin binding of short cationic antimicrobial micropeptides and its influence on the in vitro bactericidal effect","volume":"50","author":"Svenson","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2021.114470_b0330","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1002\/anie.202000505","article-title":"Poly(2-oxazoline)-based functional peptide mimics: eradicating MRSA infections and persisters while alleviating antimicrobial resistance","volume":"59","author":"Zhou","year":"2020","journal-title":"Angew. Chem."},{"key":"10.1016\/j.bcp.2021.114470_b0335","doi-asserted-by":"crossref","first-page":"10378","DOI":"10.1074\/jbc.M412865200","article-title":"A molecular mechanism for lipopolysaccharide protection of Gram-negative bacteria from antimicrobial peptides","volume":"280","author":"Papo","year":"2005","journal-title":"J. Biological Chem."},{"key":"10.1016\/j.bcp.2021.114470_b0340","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/MMBR.00013-14","article-title":"Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics","volume":"78","author":"Lebeaux","year":"2014","journal-title":"Microbiol. Mol. Biol. Rev.: MMBR."},{"key":"10.1016\/j.bcp.2021.114470_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/biom9060249","article-title":"Bioevaluation of ranatuerin-2Pb from the frog skin secretion of Rana pipiens and its truncated analogues","volume":"9","author":"Zhou","year":"2019","journal-title":"Biomolecules"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:26:48Z","timestamp":1757770008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":69,"alternative-id":["S0006295221000666"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114470","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial peptides with symmetric structures against multidrug-resistant bacteria while alleviating antimicrobial resistance","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114470"}}